Trial · NCT02291237
Results by group20
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 20
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in Peak Oxygen Uptake (VO2) Achieved During Cardiopulmonary Exercise Testing (CPET) From Baseline to Week 24 | Eleclazine 30/3/6 mg | 0.15 | Standard Deviation 4.312 | mL/kg/min | |
| Change in Peak Oxygen Uptake (VO2) Achieved During Cardiopulmonary Exercise Testing (CPET) From Baseline to Week 24 | Placebo | 0.48 | Standard Deviation 4.143 | mL/kg/min | |
| Change in Peak Oxygen Uptake (VO2) Achieved During Cardiopulmonary Exercise Testing (CPET) From Baseline to Week 12 | Eleclazine 30/3/6 mg | 0.28 | Standard Deviation 4.028 | mL/kg/min | |
| Change in Peak Oxygen Uptake (VO2) Achieved During Cardiopulmonary Exercise Testing (CPET) From Baseline to Week 12 | Placebo | 0.57 | Standard Deviation 4.314 | mL/kg/min | |
| Change in Minnesota Living With Heart Failure Questionnaire (MLHFQ) From Baseline to Week 24 | Eleclazine 30/3/6 mg | Baseline | 40.22 | Standard Deviation 25.544 | Score |
| Change in Minnesota Living With Heart Failure Questionnaire (MLHFQ) From Baseline to Week 24 | Placebo | Baseline | 38.80 | Standard Deviation 23.177 | Score |
| Change in Minnesota Living With Heart Failure Questionnaire (MLHFQ) From Baseline to Week 24 | Eleclazine 30/3/6 mg | Change from Baseline at Week 24 | -4.05 | Standard Deviation 15.164 | Score |
| Change in Minnesota Living With Heart Failure Questionnaire (MLHFQ) From Baseline to Week 24 | Placebo | Change from Baseline at Week 24 | -5.57 | Standard Deviation 14.345 | Score |
| Change in Minnesota Living With Heart Failure Questionnaire (MLHFQ) From Baseline to Week 12 | Eleclazine 30/3/6 mg | Baseline | 40.22 | Standard Deviation 25.544 | Score |
| Change in Minnesota Living With Heart Failure Questionnaire (MLHFQ) From Baseline to Week 12 | Placebo | Baseline | 38.80 | Standard Deviation 23.177 | Score |
| Change in Minnesota Living With Heart Failure Questionnaire (MLHFQ) From Baseline to Week 12 | Eleclazine 30/3/6 mg | Change at Week 12 | -3.84 | Standard Deviation 15.654 | Score |
| Change in Minnesota Living With Heart Failure Questionnaire (MLHFQ) From Baseline to Week 12 | Placebo | Change at Week 12 | -3.40 | Standard Deviation 13.780 | Score |
| Change in Treadmill Exercise Time From Baseline to Week 24 | Eleclazine 30/3/6 mg | Baseline | 12.88 | Standard Deviation 4.641 | min |
| Change in Treadmill Exercise Time From Baseline to Week 24 | Placebo | Baseline | 13.60 | Standard Deviation 4.317 | min |
| Change in Treadmill Exercise Time From Baseline to Week 24 | Eleclazine 30/3/6 mg | Change from Baseline at Week 24 | 0.27 | Standard Deviation 3.954 | min |
| Change in Treadmill Exercise Time From Baseline to Week 24 | Placebo | Change from Baseline at Week 24 | 0.24 | Standard Deviation 3.208 | min |
| Change in Treadmill Exercise Time From Baseline to Week 12 | Eleclazine 30/3/6 mg | Baseline | 12.88 | Standard Deviation 4.641 | min |
| Change in Treadmill Exercise Time From Baseline to Week 12 | Placebo | Baseline | 13.60 | Standard Deviation 4.317 | min |
| Change in Treadmill Exercise Time From Baseline to Week 12 | Eleclazine 30/3/6 mg | Change from Baseline at Week 12 | 0.48 | Standard Deviation 3.295 | min |
| Change in Treadmill Exercise Time From Baseline to Week 12 | Placebo | Change from Baseline at Week 12 | 0.38 | Standard Deviation 3.030 | min |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02291237/results